Embecta's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Embecta's ROI in the third quarter of 2026?
Embecta Corp achieved a return on average invested assets (ROI) of 11.62 % in its third quarter of 2026, which is below Embecta's average return on investment, which stands at 15.75%.

ROI fell compared to the second quarter of 2026, despite the net income growth of % from the second quarter of 2026.

Within the Healthcare sector 76 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 505 to 511.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter
Y / Y Investment Change TTM	-6.33 %	-9.15 %	-8.02 %	-3.73 %	0.7 %
Y / Y Net Income Change TTM	4.67 %	111.93 %	376.11 %	225.6 %	468.71 %
Investment (TTM) in Millions	846	691	738	738	789
Return On Investment (TTM)	11.62 %	15.14 %	18.37 %	12.2 %	10.4 %
EMBC's Overall Ranking	# 511	# 505	# 116	# 0	# 0
Seq. Investment Change TTM	1.9 %	-2.7 %	-2.84 %	-2.76 %	-1.16 %
Seq. Net Income Change TTM	-21.81 %	-19.78 %	46.23 %	14.11 %	58.33 %
Net Income (TTM) in Millions	88	112	140	95	84

EMBC Company Profile >> Back to EMBC Roi Comparisons >> See Annual EMBC Return On Investment

Return On Investment EMBC's Ranking
Within:	No.
Industry	# 23
Sector	# 77
Overall	# 511

Return On Investment Statistics
High	Average	Low
47.91 %	15.75 %	6.09 %
(Mar 31 2022)		(Jun 30 2023)

News about Embecta Corp Return on Investment ROI

Embecta Rings Nasdaq Bell for Diabetes Awareness Month While Navigating Financial Challenges with Innovative Solutions,

November 7, 2024

November is National Diabetes Awareness Month, a time dedicated to raising awareness about diabetes and promoting better care solutions for those affected by this chronic disease. In a bold display of commitment to advancing diabetes management, Embecta Corp recently celebrated this important month by ringing the Nasdaq Closing Bell, joined by key diabetes advocacy groups. This event underscores the company s dedication to supporting the diabetes community and driving progress in treatment options.Embecta has made significant strides in diabetes care, particularly with the recent FDA approval of its revolutionary disposable insulin patch pump designed specifically for individuals managing Type 2 diabetes. This state-of-the-art system boasts a 300-unit insulin reservoir and addresses the unique challenges faced by Type 2 diabetes patients, who often struggle with outdated delivery methods that involve multiple daily injections or cumbersome equipment. Embecta’s patch pump is envisioned as an innovative solution that enhances ease of use, privacy, and reliability, transforming daily diabetes management for many individuals.

Financial Statements
Embecta's III. Quarter Investments	$ 846 Millions	EMBC's Balance sheet
Embecta's III. Quarter Income	$ 21 Millions	Quarterly EMBC's Income Statement
EMBC's Income by Division		See EMBC's Income by Division

EMBC Annual Return On Investment	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022
Total Investments in Millions	738	827	772	707	0
Y / Y Investment Growth	-10.75 %	7.1 %	9.27 %	-	-
Net Income in Millions	95	78	70	224	0
Y / Y Net Income Growth	21.84 %	11.22 %	-68.52 %	-	-
Annual Return On Investment	12.93 %	9.47 %	9.12 %	31.64 %	-

Annual Roi Comment

In the fiscal year 2025 ROI improved to 12.93 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EMBC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EMBC's Competitors
Subscribers only: Roi for Embecta's Suppliers
Subscribers only: Return On Investment for EMBC's Customers

Other Ratios
EMBC's Roa	EMBC's Inventory Turnover Ratio	EMBC's Growth Rates	EMBC's Dividend Statistics
	EMBC's Profitability Ratios	EMBC's Asset Turnover Ratio	EMBC's Dividend Growth
EMBC's Roe	EMBC's Valuation Ratios	EMBC's Financial Strength Ratios	EMBC's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Acadia Pharmaceuticals Inc	31.05 %
Caredx Inc	29.42 %
Adma Biologics Inc	28.94 %
Protalix Biotherapeutics inc	25.72 %
Pro dex Inc	24.29 %
Innoviva Inc	23.33 %
Electromed Inc	23.18 %
Zevra Therapeutics Inc	22.90 %
Iradimed Corporation	22.57 %
Alnylam Pharmaceuticals Inc	22.10 %
Eton Pharmaceuticals Inc	21.31 %
Dexcom Inc	20.98 %
Healthcare Services Group Inc	20.93 %
Arcutis Biotherapeutics Inc	20.77 %
Chemed Corporation	20.13 %
Resmed Inc	20.01 %
Halozyme Therapeutics Inc	19.99 %
Vertex Pharmaceuticals Inc	19.97 %
Agilent Technologies inc	19.84 %
Illumina Inc	19.61 %
Puma Biotechnology Inc	19.60 %
United Therapeutics Corporation	19.53 %
Zoetis Inc	19.44 %
Krystal Biotech Inc	19.16 %
Carlisle Companies Incorporated	18.88 %
Neurocrine Biosciences Inc	17.51 %
Intuitive Surgical Inc	17.11 %
Theravance Biopharma inc	17.10 %
Standard Biotools Inc	16.38 %
Inspire Medical Systems inc	16.34 %

Date modified: 2026-09-08T17:34:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.